1. Home
  2. EIC vs TMCI Comparison

EIC vs TMCI Comparison

Compare EIC & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EIC
  • TMCI
  • Stock Information
  • Founded
  • EIC N/A
  • TMCI 2014
  • Country
  • EIC United States
  • TMCI United States
  • Employees
  • EIC N/A
  • TMCI N/A
  • Industry
  • EIC Finance/Investors Services
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • EIC Finance
  • TMCI Health Care
  • Exchange
  • EIC Nasdaq
  • TMCI Nasdaq
  • Market Cap
  • EIC 335.9M
  • TMCI 371.1M
  • IPO Year
  • EIC 2019
  • TMCI 2021
  • Fundamental
  • Price
  • EIC $13.38
  • TMCI $5.53
  • Analyst Decision
  • EIC Strong Buy
  • TMCI Hold
  • Analyst Count
  • EIC 1
  • TMCI 6
  • Target Price
  • EIC $17.50
  • TMCI $9.18
  • AVG Volume (30 Days)
  • EIC 497.5K
  • TMCI 352.4K
  • Earning Date
  • EIC 08-05-2025
  • TMCI 08-05-2025
  • Dividend Yield
  • EIC 16.34%
  • TMCI N/A
  • EPS Growth
  • EIC N/A
  • TMCI N/A
  • EPS
  • EIC 0.55
  • TMCI N/A
  • Revenue
  • EIC $51,224,692.00
  • TMCI $210,819,000.00
  • Revenue This Year
  • EIC $42.67
  • TMCI $10.61
  • Revenue Next Year
  • EIC $29.16
  • TMCI $10.36
  • P/E Ratio
  • EIC $24.29
  • TMCI N/A
  • Revenue Growth
  • EIC 68.61
  • TMCI 7.54
  • 52 Week Low
  • EIC $12.63
  • TMCI $4.54
  • 52 Week High
  • EIC $16.71
  • TMCI $10.79
  • Technical
  • Relative Strength Index (RSI)
  • EIC 46.79
  • TMCI 34.86
  • Support Level
  • EIC $13.07
  • TMCI $5.36
  • Resistance Level
  • EIC $13.44
  • TMCI $6.28
  • Average True Range (ATR)
  • EIC 0.23
  • TMCI 0.24
  • MACD
  • EIC 0.06
  • TMCI -0.00
  • Stochastic Oscillator
  • EIC 92.59
  • TMCI 16.30

About EIC Eagle Point Income Company Inc.

Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Share on Social Networks: